Home › Agent Hub › Agent Tools › Part D coverage by drug › Breyna
Agent Tools
Breyna is a brand of budesonide / formoterol. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 2,901 of 5,492 Medicare Part D and Medicare Advantage drug plans (52.8%) list Breyna on their formulary, across 250 of 286 formularies. The most common placement is tier 3 (1,108 plans, 38.2% of those covering it). 0 of the covering plans require prior authorization (0%), 29 step therapy and 2,788 a quantity limit. Generic budesonide / formoterol is on 5,492 of 5,492 plans (100%).
976 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $3.50, 485 of them $0; 1,925 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 2,980 of 5,496 plans covered it (54.2%); 2027: 2,901 of 5,492 (52.8%).
Of 4,367 plans offered in both years, 17 added it to the formulary and 112 dropped it.
Among plans covering it both years, 147 moved it to a higher tier and 565 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 95 |
| Tier 2 | 1,095 |
| Tier 3 | 1,108 |
| Tier 4 | 603 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 128 of 323 | 39.6% | 0% |
| Medicare Advantage with drugs (MA-PD) | 1,667 of 3,200 | 52.1% | 0% |
| Special needs plans (SNP) | 1,106 of 1,969 | 56.2% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 0 of 830 | No tier listed | 0 |
| Devoted Health | 728 of 728 | Tier 2 | 0 |
| Aetna Medicare | 0 of 631 | No tier listed | 0 |
| Wellcare | 268 of 268 | Tier 2 | 0 |
| HealthSpring | 226 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 112 of 112 | Tier 2 | 0 |
| SCAN Health Plan | 83 of 83 | Tier 4 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 2 | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 36 of 36 | Tier 2 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 4 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 4 | 0 |
| Medica | 27 of 27 | Tier 4 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 68 of 114 | 59.6% |
| Alaska | 3 of 9 | 33.3% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 97 of 147 | 66% |
| Arkansas | 37 of 85 | 43.5% |
| California | 300 of 397 | 75.6% |
| Colorado | 55 of 106 | 51.9% |
| Connecticut | 27 of 54 | 50% |
| Delaware | 16 of 43 | 37.2% |
| District of Columbia | 4 of 12 | 33.3% |
| Florida | 297 of 545 | 54.5% |
| Georgia | 72 of 149 | 48.3% |
| Guam | 0 of 1 | 0% |
| Hawaii | 34 of 50 | 68% |
| Idaho | 17 of 45 | 37.8% |
| Illinois | 62 of 132 | 47% |
| Indiana | 70 of 138 | 50.7% |
| Iowa | 30 of 64 | 46.9% |
| Kansas | 25 of 84 | 29.8% |
| Kentucky | 44 of 121 | 36.4% |
| Louisiana | 52 of 125 | 41.6% |
| Maine | 20 of 52 | 38.5% |
| Maryland | 35 of 49 | 71.4% |
| Massachusetts | 63 of 89 | 70.8% |
| Michigan | 139 of 182 | 76.4% |
| Minnesota | 44 of 63 | 69.8% |
| Mississippi | 47 of 104 | 45.2% |
| Missouri | 65 of 170 | 38.2% |
| Montana | 6 of 27 | 22.2% |
| Nebraska | 26 of 51 | 51% |
| Nevada | 47 of 100 | 47% |
| New Hampshire | 9 of 25 | 36% |
| New Jersey | 30 of 73 | 41.1% |
| New Mexico | 23 of 68 | 33.8% |
| New York | 104 of 215 | 48.4% |
| North Carolina | 94 of 176 | 53.4% |
| North Dakota | 14 of 26 | 53.8% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 98 of 171 | 57.3% |
| Oklahoma | 30 of 81 | 37% |
| Oregon | 67 of 92 | 72.8% |
| Pennsylvania | 149 of 323 | 46.1% |
| Puerto Rico | 22 of 64 | 34.4% |
| Rhode Island | 12 of 29 | 41.4% |
| South Carolina | 41 of 89 | 46.1% |
| South Dakota | 16 of 30 | 53.3% |
| Tennessee | 101 of 156 | 64.7% |
| Texas | 214 of 407 | 52.6% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 16 of 53 | 30.2% |
| Vermont | 5 of 14 | 35.7% |
| Virginia | 48 of 144 | 33.3% |
| Washington | 64 of 114 | 56.1% |
| West Virginia | 17 of 69 | 24.6% |
| Wisconsin | 46 of 96 | 47.9% |
| Wyoming | 6 of 13 | 46.2% |
Medicare Part D paid for 788,511 30-day fills of Breyna in 2024 for about 211,122 enrollees, at an average total cost of $146.59 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Breyna and the rest of a client's list on every plan in their county.
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.